Industry Articles
Updates about sleep-related diagnostic devices, therapies, products and companies

FDA clears circul pro Ring as pulse oximeter

On Sep. 7, 2023, BodiMetrics announced that its circul pro Ring has received FDA 510(k) clearance as a pulse oximeter. According to the company, the device’s form factor and LED technology make it uniquely designed to accurately measure blood oxygen level on people with any skin [...]

2024-09-24T21:10:06-05:00September 9th, 2023|Industry|

FDA approves remedē System for MRI conditional use

On May 24, 2023, Zoll announced the FDA has approved the remedē System for conditional use with magnetic resonance imaging (MRI). The implantable transvenous phrenic nerve stimulation therapy is a treatment for adults with moderate to severe central sleep apnea (CSA). About the [...]

2024-09-24T21:13:02-05:00May 25th, 2023|Industry|

FDA clears Cumulus dry-sensor EEG headset

Cumulus Neuroscience announced on May 4, 2023, that its dry-sensor electroencephalograph (EEG) headset has received FDA 510(k) clearance. The device is FDA-cleared for use in adults and adolescents for the remote acquisition, display and storage of EEG data. About the Cumulus EEG headset [...]

2024-09-24T21:19:36-05:00May 5th, 2023|Industry|

Avadel receives FDA approval for Lumryz

Avadel Pharmaceuticals announced on May 1, 2023 that the FDA granted final approval to Lumryz, an extended-released sodium oxybate medication. It is taken once at bedtime for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. About Lumryz [...]

2024-10-22T11:29:41-05:00May 2nd, 2023|Industry|

AASM names gold standard panel of manual scorers

The AASM has created a gold standard of sleep records to validate third party automated sleep scoring algorithms for the Autoscoring Certification: Sleep Stage Pilot Program. The goal of this project is to establish objective performance requirements for third party automated sleep scoring [...]

2025-01-24T09:26:42-06:00April 26th, 2023|Industry|

FDA grants De Novo request for restless legs syndrome therapy

On April 19, 2023, Noctrix Health announced it received FDA De Novo approval for its NTX100 Tonic Motor Activation (TOMAC) System, which is intended to treat symptoms of moderate to severe restless legs syndrome (RLS) and improve sleep quality in patients who are refractory [...]

2024-09-24T21:23:29-05:00April 20th, 2023|Industry|

SNOO Smart Sleeper granted FDA De Novo approval

On April 3, 2023, Happiest Baby announced the FDA granted De Novo approval to its SNOO Smart Sleeper, which keeps sleeping babies safely positioned on their back and uses continuous rhythmic sensations that mimic the experience of being in the womb. About the [...]

2024-09-24T21:26:46-05:00April 4th, 2023|Industry|
Go to Top